MAGED1 and esophageal squamous cell carcinoma: To further investigate the role of the Wnt/β-catenin signaling pathway in radioresistance of ESCC regulated by NRAGE, FH535 (HY-15721, MCE, USA), a reversible inhibitor of the Wnt pathway, was used.